Smart-Money SignalNeutral · 54/100— Insiders are net buyers over 90 days ($50K, 1 buy vs 0 sales)
Revenue$190.0K
Net Income-$10.3M
EPS$-0.22
Market Cap$49.2M
Price Performance
Historical data including institutional events
Company Profile
S
Sanjay S Shukla
CEO & Executive Director
aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.